𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatorenal syndrome – how to assess response to treatment and nonpharmacological therapy

✍ Scribed by V. Arroyo

Book ID
108603732
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
67 KB
Volume
20
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of response to therapy with t
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
✍ André Nazar; Gustavo Henrique Pereira; Mónica Guevara; Marta Martín-Llahi; Marie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

Use of oesophagogastroscopy to assess th
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy
✍ W. A. Brown; J. Thomas; D. Gotley; B. H. Burmeister; K.-H. Lim; I. Martin; E. T. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## Background Approximately 25 per cent of patients with oesophageal cancer who undergo neoadjuvant chemoradiotherapy have no evidence of tumour in the resected specimen (complete pathological response). Those who do not respond have a poor 5-year survival compared with complete respon